In-silico analysis of potential anticancer drug for NEK7 and PPP1CA proteins overexpressed in pancreatic ductal adenocarcinoma-Reference-Cited by-同舟云学术

In-silico analysis of potential anticancer drug for NEK7 and PPP1CA proteins overexpressed in pancreatic ductal adenocarcinoma

Published:2024-03-12 Issue: Volume: Page:1-17
ISSN:0739-1102
Container-title:Journal of Biomolecular Structure and Dynamics
language:en
Short-container-title:Journal of Biomolecular Structure and Dynamics

Author:

Adrees Safa¹,Imtiaz Anam¹,Yaseen Aiman¹,Irfan Fareed Muhammad¹,Anwar Waqar¹,Ashraf Asma²,Shabbir Rana Muhammad Kamran²,Andlib Shaista³,Hussain Mureed¹⁴,Tariq Asma⁵,Mateen Rana Muhammad¹⁶,Saqib Muhammad Arif Nadeem⁷,Parveen Rukhsana⁶

Affiliation:

1. Department of Life sciences, School of Science, University of Management and Technology, Lahore, Pakistan

2. Department of Zoology, Division of science and Technology, University of Education, Lahore, Pakistan

3. Department of Microbiology, Faculty of Biological Sciences, Quaid-e-Azam University, Islamabad, Pakistan

4. Center for Regenerative Medicine and Stem Cell Research, Agha Khan University, Karachi, Pakistan

5. School of Biochemistry and Biotechnology, University of the Punjab, Lahore, Pakistan

6. Centre for Applied Molecular Biology, University of the Punjab, Lahore, Pakistan

7. Department of Medical Laboratory Technology, National Skill University, Islamabad, Pakistan

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/07391102.2024.2318484

Reference42 articles.

1. In silico identification of therapeutic compounds against microRNA targets in drug-resistant pancreatic ductal adenocarcinoma

2. Identification of NEK7 inhibitors: Structure based virtual screening, molecular docking, density functional theory calculations and molecular dynamics simulations;Aziz M.;Journal of Biomolecular Structure & Dynamics,2023

3. Identification of potent inhibitors of NEK7 protein using a comprehensive computational approach

4. BDDCS, the Rule of 5 and drugability

5. Biovia, D. S. (2021). Discovery Studio Visualizer v21. 1.0. 20298. Dassault Systèmes.